Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor
about
Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathwayRelationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculaturePerlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfateThe mechanisms of coronary restenosis: insights from experimental models.In vivo quantitative assessment of catheter patency in rats.Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling.Characterization of the chemotactic and mitogenic response of SMCs to PDGF-BB and FGF-2 in fibrin hydrogelsHeparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the ratPlatelet factor 4 modulates the mitogenic activity of basic fibroblast growth factorNext generation of electrosprayed fibers for tissue regeneration.Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis.Neointima formation after acute vascular injury. Role of counteradhesive extracellular matrix proteinsRegulation of smooth muscle cell growth by endothelium-derived factors.Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Strain-dependent vascular remodeling phenotypes in inbred mice.Smooth Muscle Stiffness Sensitivity is Driven by Soluble and Insoluble ECM ChemistryHeparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways.Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.Role of the soluble pattern recognition receptor PTX3 in vascular biologyHeparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype.The role of endothelial cells and their progenitors in intimal hyperplasia.Mitochondrial dynamics, mitophagy and cardiovascular disease.Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid arteryNitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques.A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickeningEntry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury.Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.
P2860
Q24649727-56F9D1AF-89A4-4753-8304-8536E6525474Q28292534-16F27B64-48EC-4779-8247-ED0CF7C6F43EQ28583399-7AA2C0A1-6929-40DE-A00F-D67D377646E1Q33890371-76B67352-DE0F-4718-8352-B0D8790A220DQ33909316-97EF31AE-2C2A-4972-A7CA-3E1572E3120FQ33912429-7163A982-4FDE-4414-9942-08428B80CB56Q34083818-1742A553-7643-44D7-8010-C7567018DE80Q34143433-58CAF1D0-D00C-473C-96B4-7B43AE6B6028Q34146262-0C1D7895-27D6-4492-ADCC-7777BF3FCAAAQ34211840-FCB8BDD8-D055-4CA2-B695-B3541B9CF7CAQ34235387-B82C50F4-0378-4E6C-B222-F2FDD2F564AEQ34707891-FE6A8E17-B1BA-455B-AD95-A29FAD52D227Q35028855-EE664355-10C5-49B6-87DF-24ED5D52FA48Q35652135-F5A0993D-E140-43B5-ADCB-A65F297B8887Q35652173-E33CB539-3E7B-4976-AAE2-DB6B5FE09588Q35693444-8E900DE9-F0DA-43C3-A765-02D42B067E8FQ35766125-B2943792-1992-40E2-AFF4-59777866CF04Q35810132-B9E60B0C-4635-468D-A139-76E6A54BFFF0Q36175769-687E3922-E9D6-445B-BC92-383EA7A726EFQ36711399-88ED0938-A4AE-434D-8FB6-3D1D655643B4Q36868851-0FBB70D8-8ECB-4CC6-8523-1DCED9ED853FQ36924394-BF51F2F1-4240-49E2-A7F2-136A277294C2Q37395446-FD9C986D-62B4-4D33-AC81-74396BD5974DQ37411237-25AE31FF-21A0-4B3C-8768-16F67B41F52CQ37702032-13A4B2E7-2284-4743-B904-5A73EA73050DQ38625440-6B542882-8CE3-409B-9042-36E499BE6B7FQ39416600-12471028-C6A1-41C4-AFAC-92FFC2625835Q40342088-5776DFD5-C901-4C8C-A7AD-45C9B5514823Q41810809-79F8DB4E-3EE8-400A-B0BB-384980171FD4Q41931107-98CCB5CF-02D7-4860-90F5-293D2A06DB82Q41934611-8A99BC4F-8B64-4952-9ED4-DC7572A1B6A5Q42113999-6A8FEE66-EE9A-4A99-B4AC-E44A23263AB3
P2860
Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Inhibition of smooth muscle ce ...... basic fibroblast growth factor
@ast
Inhibition of smooth muscle ce ...... basic fibroblast growth factor
@en
type
label
Inhibition of smooth muscle ce ...... basic fibroblast growth factor
@ast
Inhibition of smooth muscle ce ...... basic fibroblast growth factor
@en
prefLabel
Inhibition of smooth muscle ce ...... basic fibroblast growth factor
@ast
Inhibition of smooth muscle ce ...... basic fibroblast growth factor
@en
P2093
P2860
P356
P1476
Inhibition of smooth muscle ce ...... basic fibroblast growth factor
@en
P2093
P2860
P304
P356
10.1172/JCI116085
P407
P577
1992-11-01T00:00:00Z